Pravesh Khandelwal
Investor Relations Contact chez EMBECTA CORP.
Profil
Pravesh Khandelwal is currently the Vice President & Head-Investor Relations at Embecta Corp.
Prior to this, he worked as a Research Associate at Deutsche Bank Securities, Inc. from 2014 to 2019.
He also worked as a Financial Modeling Associate at Bloomberg LP (Research) from 2008 to 2014.
Additionally, he served as the Head-Investor Relations at Endo International Plc.
Mr. Khandelwal holds an MBA from Pace University and an undergraduate degree from the University of Pune.
Postes actifs de Pravesh Khandelwal
| Sociétés | Poste | Début |
|---|---|---|
| EMBECTA CORP. | Investor Relations Contact | 01/06/2022 |
Anciens postes connus de Pravesh Khandelwal
| Sociétés | Poste | Fin |
|---|---|---|
| ENDO INTERNATIONAL PLC | Public Communications Contact | 01/06/2022 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Analyst-Equity | 01/01/2019 |
Bloomberg LP (Research)
 Bloomberg LP (Research) Investment ManagersFinance Bloomberg LP (Research) is the investment research division of Bloomberg LP, which is owned by Bloomberg, Inc. in the US. Headquartered in New York City, the firm was founded in 2007 and provides research, long-term forecasts, analytical tools and global in-depth analysis covering a wide range of industries. | Corporate Officer/Principal | 31/08/2014 |
Formation de Pravesh Khandelwal
| University of Pune | Undergraduate Degree |
| Pace University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EMBECTA CORP. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Bloomberg LP (Research)
Bloomberg LP (Research) Investment ManagersFinance Bloomberg LP (Research) is the investment research division of Bloomberg LP, which is owned by Bloomberg, Inc. in the US. Headquartered in New York City, the firm was founded in 2007 and provides research, long-term forecasts, analytical tools and global in-depth analysis covering a wide range of industries. | Finance |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
